News

Nitrates, including cardiac medications and food additives, are common headache triggers, mediated by nitric oxide, a potent vasodilator.

A single treatment giving life-long protection from severe allergies such as asthma could be made possible by recent immunology research.

Epigenetic changes are chemical modifications that turn our genes off or on. In a new study from Uppsala University, researchers show that tea consumption in women leads to epigenetic changes in genes that are known to interact with cancer and estrogen metabolism.

This new method can stimulate deep parts of the brain without surgery and — if it pans out in humans — it could be very helpful for people with neurological conditions like Parkinson’s, depression, or epilepsy.

Changes in immune activity appear to signal a growing brain tumor five years before symptoms arise, new research has found.

Although thinking about dying can cause considerable angst, new research suggests that the actual emotional experiences of the dying are both more positive and less negative than people expect.

Scientists from Cambridge and Vienna present a new method that combines the organoid method with bioengineering

Clinicians continue to add to the system’s cancer-assessing repertoire.

Researchers found that a molecule called PD-L1, which is blocked by the immunotherapy drug nivolumab, acts not only on immune cells but also on the nerve cells that signal pain. That insight could lead to a simple test that measures subtle differences in pain sensitivity to gauge whether or not a cancer patient is responding to immunotherapy. This study also identifies PD-L1 as a previously unrecognized neuromodulator and pain inhibitor.

A new plasmonic sensor developed by researchers at the University of Illinois at Urbana-Champaign will serve as a reliable early detection of biomarkers for many forms of cancer and eventually other diseases.